Your Location:
Home >
Browse articles >
Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss
Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss
- “In the field of Alzheimer's disease research, this study elucidates distinct protein and phosphoprotein networks between dorsal and ventral hippocampal CA1 regions, highlighting the susceptibility of the vCA1 microcircuit to AD-like tau accumulation. Notably, the efficacy of ursolic acid in reducing tau load and targeting the vCA1 microcircuit may provide a promising strategy for treating AD in the future.”
- Military Medical Research Vol. 12, Issue 1, Pages: 48-71(2025)
DOI: 10.1186/s40779-024-00512-z
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 8 ) Tabs( 0 )
References
Publication Info
Metrics
29
Views
38
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
E3 ubiquitin ligases in neurodegenerative diseases
Dementia in military and veteran populations: a review of risk factors—traumatic brain injury, post-traumatic stress disorder, deployment, and sleep
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Related Author
Duan Lu Hou
Josephine Ho
Tuchen Guan
Xiao-Xue Dong
Li Zeng
Laurie H Sanders
Yun-Cheng Wu
Eng King Tan
Related Institution
National Neuroscience Institute
Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Nanyang Technological University
Departments of Neurology and Pathology, Duke University School of Medicine
Duke Center for Neurodegeneration and Neurotherapeutics, Duke University

